CBD	cannabidiol
Δ9-THC	Δ9-tetrahydro-cannabinol
Nrf2	nuclear factor erythroid 2 – related factor 2
SOD	superoxide dismutase
GSH	glutathione
ROS	reactive oxygen species
iNOS	inducible nitric oxide synthase
IL-6	interleukin-6
IL-1β	interleukin-1β
TNF-α	tumor necrosis factor α
NF-κB	nuclear factor κB
PPARγ	peroxisome proliferator-activated receptor γ
TRP	transient receptor potential
TRPV	transient receptor potential vanilloid
CB1	cannabinoid receptor type 1
CB2	cannabinoid receptor type 2
2-AG	2-arachidonoyl glycerol
AEA	arachidonoylethanolamide
ECS	endocannabinoid system
Ca2+	calcium
FAAH	fatty acid amide hydrolase
GABA	γ-aminobutyric acid
5-HT	Serotonin
GPCRs	G protein-coupled receptors
ARs	adenosine receptors
BBB	blood–brain barrier
CYPs	cytochrome P450 enzymes
7-OH-CBD	7-hydroxycannabidiol
Gi/o	inhibiting G
cAMP	cyclic adenosine monophosphate
PI3K/Akt	phosphoinositide 3-kinases/protein kinase B
CNS	central nervous system
TMEV	Theiler’s murine encephalomyelitis virus
i.p.	intraperitoneal
VCAM-1	vascular cell adhesion molecule-1
CCL2	chemokine 2
CCL5	chemokine 5
COX-2	cyclooxygenase-2
Aβ	amyloid-β
BDNF	brain-derived neurotrophic factor
K+	potassium
MCA	middle cerebral artery occlusion
PTZ	pentylenetetrazole
i.v.	intravenous
GPR55	G protein-coupled receptors 55
ERK	extracellular receptor-activated kinases
DS	Dravet syndrome
MPTP	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
EAE	experimental autoimmune encephalomyelitis
TRPA1	transient receptor potential ankyrin 1
TRPM8	transient receptor potential cation channel subfamily M member 8
hPBMECs	human Primary Brain Microvascular Endothelial Cells
GSK-3β	glycogen synthase kinase 3β
SH-SY5YAPP+	SH-SY5Y cells transfected with the amyloid precursor protein
l-DOPA	l-3,4-Dihydroxyphenylalanine
6-OHDA	6-hydroxydopamine
AA-5-HT	arachidonoyl-serotonin
IFN-γ	interferon-γ
IL-17	interleukin-17
TSC	tuberous sclerosis complex
CLB	clobazam
N-CLB	N-desmethylclobazam
Scn1a+/−	heterozygous loss of function SCN1A